SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kleihues PC, Burger PC, Scheithauer BW. Histological typing of tumor of the central nervous system. In: ScheithauerBW, editor. World Health Organization international histology classification of tumors, 2nd ed. Berlin: Springer, 1993.
  • 2
    Gjerris F, Agerlin N, Borgesen SE, Buhl L, Haase J, Klinken L, et al. Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960–1984. Child Nerv Syst 1998; 14: 30211.
  • 3
    Hjalmars U, Kulldorff M, Wahlqvist Y, Lannering B. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973–1992: a population-based study of pediatric brain tumors. Cancer 1999; 85: 207790.
  • 4
    Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 1995; 75: 272731.
  • 5
    Heideman RL, Kuttesch J Jr., Gajjar AJ, Walter AW, Jenkins JJ, Li Y, et al. Supratentorial malignant gliomas in childhood: a single institution perspective. Cancer 1997;80: 497504.
  • 6
    Wisoff JH, Boyett JM, Berger MS, Brant C, Li H, Yates AJ, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg 1998;89: 529.
  • 7
    Sheline GE. Radiation therapy of brain tumors. Cancer 1977; 39(Suppl 2): S87381.
  • 8
    Johnson JH Jr., Phillips PC. Malignant gliomas in children. Cancer Invest 1996;14: 60921.
  • 9
    Parker FG II, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996; 84: 4428.
  • 10
    Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children's Cancer Study Group. J Neuro-Oncol 1989;97: 16577.
  • 11
    Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al. Randomized Phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J Clin Oncol 1995;13: 11223.
  • 12
    Kuhl J, Muller HL, Berthold F, Kortmann RD, Deinlein F, Maass E, et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT '88/'89. Klin Padiatr 1998; 210: 22733.
  • 13
    Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budah V, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000; 15: 26979.
  • 14
    Packer RJ, Finlay JL. Chemotherapy for childhood medulloblastoma and primitive neuroectodermal tumors. Oncologist 1996; 1: 38193.
  • 15
    Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, et al. Treatment of children with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group study. J Clin Oncol 1999; 17: 2127.
  • 16
    Wolff JE, Boos J, Kuhl J. HIT-GBM: multicenter study of treatment of children with malignant glioma. Klin Padiatr 1996; 208: 1936.
  • 17
    Wolff JEA, Moelenkamp G, Westphal S, Pietsch T, Gnekow A, Kortmann RD, et al. Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer 2000; 89(10): 21317.
  • 18
    Finlay JL, Wisoff JH. The impact of extent of resection in the management of malignant gliomas of childhood. Child Nerv Syst 1999; 15: 7868.
  • 19
    Jeremic B, Grulicic D, Samardzic M, Antunovic V, Joksimovic M, Djuric L, et al. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme]. Srp Arh Celok Lek 1997; 125: 938.
  • 20
    Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999; 52: 3719.
  • 21
    Kreth FW, Berlis A, Spiropoulou V, Faist M, Scheremet R, Rossner R. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 1999; 86: 211723.
  • 22
    von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993; 3: 1926.
  • 23
    Poppenborg H, Münstermann G, Knüpfer M, Hotfilder M, Hacker-Klom U, Wolff JE. Cisplatin induces radioprotection in human T98G glioma cells. Anticancer Res 1997; 17: 11314.
  • 24
    Poppenborg H, Münstermann G, Knüpfer MM, Hotfilder M, Wolff JE. C6 cells cross-resistant to cisplatin and radiation. Anticancer Res 1997; 17: 20737.
  • 25
    Kirby S, Macdonald D, Fisher B, Gaspar L, Cairncross G. Pre-radiation chemotherapy for malignant glioma in adults. Can J Neurol Sci 1996; 23: 1237.
  • 26
    Brandes AA, Rigon A, Zampieri P, Scelzi E, Amista P, Berti F, et al. Early chemotherapy and concurrent radio-chemotherapy in high grade glioma. J Neurooncol 1996; 30: 24755.